Use of spiro-oxindole compounds as therapeutic agents

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/437 (2006.01) A61K 31/407 (2006.01) A61P 3/06 (2006.01) A61P 13/08 (2006.01) A61P 17/04 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2665698

This invention is directed to methods of using spiro-oxindole compounds of formula (I): wherein k, j, Q, R1, R2a, R2b, R2c, R2d, R3a, R3b, R3c, and R3d are as defined herein, as a stereoisomer, enantiomer, tautomer thereof or mixtures thereof; or a pharmaceutically acceptable salt, solvate or prodrug thereof, for the treatment and/or prevention of hypercholesterolemia, benign prostatic hyperplasia, pruritis and cancer.

Cette invention concerne l'utilisation, pour le traitement et/ou la prévention de l'hypercholestérolémie, de l'hyperplasie bénigne de la prostate, du prurit et du cancer, de composés de spiro-oxindole représentés par la formule (I). Dans cette formule, k, j, Q, R1, R2a, R2b, R2c, R2d, R3a, R3b, R3c, et R3d sont comme définis dans le descriptif, en tant que stéréoisomère, énantiomère, tautomère seuls ou en mélanges, ou bien un sel, un solvate ou un promédicament de qualité pharmaceutique de ces composés.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of spiro-oxindole compounds as therapeutic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of spiro-oxindole compounds as therapeutic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of spiro-oxindole compounds as therapeutic agents will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1559753

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.